Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Both companies have been struggling to meet massive demand for their products – Zepbound and Wegovy are both on the FDA's list of medicines in short supply – and a simpler-to-produce vial ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...

Shannon Brooks, 29, never thought she'd find herself standing in her South Side Chicago kitchen every Sunday night, mixing vials to create ... name brands [such as Wegovy],” she said.

Official data shows that since 2019, this medication has been linked to 23 deaths and 1,179 serious adverse reactions in the ...

Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating ... these compounded versions are usually dispensed in vials, which requires a syringe to draw ...